Cargando…

A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients

Repaglinide is an insulin secretagogue that often exhibits considerable interindividual variability in therapeutic efficacy. The current study was designed to investigate the impact of KCNQ1 genetic polymorphism on the efficacy of repaglinide and furthermore to identify the potential mechanism of ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xueyan, Zhu, Jing, Bao, Zejun, Shang, Zhenhai, Wang, Tao, Song, Jinfang, Sun, Juan, Li, Wei, Adelusi, Temitope Isaac, Wang, Yan, Lv, Dongmei, Lu, Qian, Yin, Xiaoxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114551/ https://www.ncbi.nlm.nih.gov/pubmed/27857189 http://dx.doi.org/10.1038/srep37293

Ejemplares similares

A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients
por: Zhou, Xueyan, et al.
Publicado: (2019)

MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus
por: Wang, Tao, et al.
Publicado: (2019)

Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus
por: Wang, Liang-Chen, et al.
Publicado: (2018)

Repaglinide-Induced Acute Pancreatitis
por: Udongwo, Ndausung, et al.
Publicado: (2021)

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013)

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2021)

Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
por: Younas, Amna, et al.
Publicado: (2021)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
por: Ma, J., et al.
Publicado: (2014)

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012)

Clinical Effects of Exercise Rehabilitation Combined with Repaglinide in the Treatment of Diabetes
por: Li, Yan, et al.
Publicado: (2022)

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
por: Omori, Kazuno, et al.
Publicado: (2018)

Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide
por: Kaushal, N., et al.
Publicado: (2010)

Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2014)

Comparison of Glycemic Excursion in Patients with New Onset Type 2 Diabetes Mellitus before and after Treatment with Repaglinide
por: Hezarkhani, Sharabeh, et al.
Publicado: (2013)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Moses, Robert
Publicado: (2009)

Clinical Study of 30 Novel KCNQ2 Variants/Deletions in KCNQ2-Related Disorders
por: Xiao, Tiantian, et al.
Publicado: (2022)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
por: Xie, Jing, et al.
Publicado: (2019)

Glucose-dependent and Glucose-sensitizing Insulinotropic Effect of Nateglinide: Comparison to Sulfonylureas and Repaglinide
por: Hu, Shiling, et al.
Publicado: (2001)

KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3
por: Soh, Heun, et al.
Publicado: (2022)

Inhibition of Key Enzymes Linked to Type 2 Diabetes and Sodium Nitroprusside Induced Lipid Peroxidation in Rats’ Pancreas by Phenolic Extracts of Avocado Pear Leaves and Fruit
por: Oboh, Ganiyu, et al.
Publicado: (2014)

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas
por: Schroner, Zbynek, et al.
Publicado: (2011)

Severe Thrombocytopenia Due to Repaglinide in a Patient With Type 2 Diabetes
por: Katsuyama, Hisayuki, et al.
Publicado: (2013)

Interaction of repaglinide with bovine serum albumin: Spectroscopic and molecular docking approaches
por: Pawar, Suma K., et al.
Publicado: (2019)

Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin
por: Kawamori, Ryuzo, et al.
Publicado: (2015)

Gating and Regulation of KCNQ1 and KCNQ1 + KCNE1 Channel Complexes
por: Wang, Yundi, et al.
Publicado: (2020)

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
por: Song, Jinfang, et al.
Publicado: (2022)

The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
por: Tanaka, Kenichi, et al.
Publicado: (2017)

Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study
por: Akagi, Yuuki, et al.
Publicado: (2020)

Development of Novel S-Protective Thiolated-Based Mucoadhesive Tablets for Repaglinide: Pharmacokinetic Study
por: Alhakamy, Nabil A., et al.
Publicado: (2022)

Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes
por: Ahmad, Mubashir, et al.
Publicado: (2023)

Variant rs2237892 of KCNQ1 Is Potentially Associated with Hypertension and Macrovascular Complications in Type 2 Diabetes Mellitus in A Chinese Han Population
por: Zhang, Wanlin, et al.
Publicado: (2015)

Association study between KCNQ1 and KCNQ1OT1 genetic polymorphisms and gastric cancer susceptibility and survival in a Chinese Han population: a case-control study
por: Yang, Zhenyu, et al.
Publicado: (2021)

Comparison of UV spectrophotometry and high performance liquid chromatography methods for the determination of repaglinide in tablets
por: Dhole, Seema M., et al.
Publicado: (2012)

Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats
por: Chukwunonso Obi, Bonaventure, et al.
Publicado: (2016)

Molecular dynamics, quantum mechanics and docking studies of some Keap1 inhibitors – An insight into the atomistic mechanisms of their antioxidant potential
por: Adelusi, Temitope Isaac, et al.
Publicado: (2021)

Swimming training alleviated insulin resistance through Wnt3a/β-catenin signaling in type 2 diabetic rats
por: Yang, Qiang, et al.
Publicado: (2017)

The Pathological Mechanisms of Hearing Loss Caused by KCNQ1 and KCNQ4 Variants
por: Homma, Kazuaki
Publicado: (2022)

Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
por: Müssig, Karsten, et al.
Publicado: (2009)

Antioxidant properties of repaglinide and its protections against cyclosporine A-induced renal tubular injury
por: Li, Dao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_epq1grsia4bsio0k08na8df7qe